Ke Zhu

Liaoning University of Traditional Chinese Medicine

H指数:19

被引数:853

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Chlorotoxin suppresses melanoma vasculogenic mimicry via LINC01235/miR-128-3p/YY1/ VEGFR2/NRP1 axis

氯毒素通过LINC01235/miR-128-3p/YY1/VEGFR2/NRP1轴抑制黑色素瘤血管生成拟态

iScience

IF4.1

2026-07-060

OAAI

Transcriptomic recovery and persistence patterns reveal the biological cost of sleep debt in healthy adult males

转录组恢复和持续模式揭示了睡眠不足对健康成年男性的生物学代价

Sleep

IF4.9

2026-04-010

PRE

Sodium selenite promotes apoptosis and augments autophagic flux in cervical cancer cells by activating the YAP-Hippo signaling pathway

亚硒酸钠通过激活YAP-Hippo信号通路促进宫颈癌细胞凋亡并增强自噬流

Translational Cancer Research

IF1.7

2026-01-310

PRE

A radiotherapeutic paradox: ellagic acid sensitizes tumors while attenuating radiation-induced myocardial injury

Frontiers in Oncology

IF3.3

2026-01-280

Synergistic immunomodulatory effects of naringenin and photothermal therapy in triple-negative breast cancer

三阴性乳腺癌中柚皮素与光热疗法的协同免疫调节作用

iScience

IF4.1

2025-11-190

OAAI

Improvement of Catalytic Activity and Thermostability of Alginate Lyase VxAly7B-CM via Rational Computational Design Strategies

通过理性计算设计策略改善 alginate lyase VxAly7B-CM 的催化活性和热稳定性

MARINE DRUGS

IF5.4

2025-05-010

Albiflorin improves osteoporotic bone regeneration by promoting osteogenesis-angiogenesis coupling of bone marrow mesenchymal stem cells

白芍苷通过促进骨髓间充质干细胞的成骨-成血管偶联作用改善骨质疏松性骨再生

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

IF2.2

2025-03-010

PRE

Anti-pyroptosis biomimetic nanoplatform loading puerarin for myocardial infarction repair: From drug discovery to drug delivery

BIOMATERIALS

IF12.9

2025-03-012

PRE

Targeted delivery of Saikosaponin A and doxorubicin via hyaluronic acid-modified ZIF-8 nanoparticles for TNBC treatment: Inhibiting metastasis and reducing cardiotoxicity

BIOMATERIALS ADVANCES

IF6

2025-02-011

PRE

Emodin in-situ delivery with Pluronic F-127 hydrogel for myocardial infarction treatment: Enhancing efficacy and reducing hepatotoxicity

LIFE SCIENCES

IF5.1

2024-10-013

PRE

Enhancing breast cancer treatment: mesoporous dopamine nanoparticles in synergy with chrysin for photothermal therapy

FRONTIERS IN ONCOLOGY

IF3.3

2024-07-092

OAAI

N-acetyl-L-cysteine-modified macrophage membrane-coated VEGF sustained-release nanoparticles for treatment of myocardial infarction: A biomimetic nano-buffer for neutralization of detrimental factors and promotion of mature angiogenesis

CHEMICAL ENGINEERING JOURNAL

IF13.2

2024-06-013

PRE

The impact of healthcare industry convergence on the performance of the public health system: a geospatial modeling study of provincial panel data from China

医疗产业融合对公共卫生系统绩效的影响 -- 基于中国省级面板数据的地理空间建模研究

FRONTIERS IN PUBLIC HEALTH

IF3.4

2023-09-120

OAAI

Aggregation-induced emission photosensitizer/bacteria biohybrids enhance Cerenkov radiation-induced photodynamic therapy by activating anti-tumor immunity for synergistic tumor treatment

ACTA BIOMATERIALIA

IF9.6

2023-09-0113

OAAI

Novel treatment from a botanical formulation Si-Miao-Yong-an decoction inhibits vasa vasorum angiogenesis and stabilizes atherosclerosis plaques via the Wnt1/β-catenin signalling pathway

植物制剂四妙勇安汤的新疗法通过Wnt1/β-catenin信号通路抑制血管新生并稳定动脉粥样硬化斑块

PHARMACEUTICAL BIOLOGY

IF4.8

2023-08-311

OAAI

Triptolide with hepatotoxicity and nephrotoxicity used in local delivery treatment of myocardial infarction by thermosensitive hydrogel

JOURNAL OF NANOBIOTECHNOLOGY

IF12.6

2023-07-1719

OAAI

Berberin sustained-release nanoparticles were enriched in infarcted rat myocardium and resolved inflammation

JOURNAL OF NANOBIOTECHNOLOGY

IF12.6

2023-01-2817

OAAI

Nectin-4-targeted immunoSPECT/CT imaging and photothermal therapy of triple-negative breast cancer

JOURNAL OF NANOBIOTECHNOLOGY

IF12.6

2022-05-2529

OAAI

Conductive nanocomposite hydrogel and mesenchymal stem cells for the treatment of myocardial infarction and non-invasive monitoring via PET/CT

JOURNAL OF NANOBIOTECHNOLOGY

IF12.6

2022-05-0630

OAAI

Novel circular RNA circ_0086722 drives tumor progression by regulating the miR-339-5p/STAT5A axis in prostate cancer

CANCER LETTERS

IF10.1

2022-05-0123

PRE

Ke Zhu

个人简介

教育背景

工作经历

荣誉奖项

研究方向